Get started
Author

Tania Payo‐Serafín

Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation
2022 · Paula Fernández-Palanca, Tania Payo-Serafín, et al. · Acta Pharmacologica Sinica · 36
Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis
2021 · Flavia Fondevila, Paula Fernández-Palanca, et al. · Cancers · 27
PDF
Neuropilin-1 as a Potential Biomarker of Prognosis and Invasive-Related Parameters in Liver and Colorectal Cancer: A Systematic Review and Meta-Analysis of Human Studies
2022 · Paula Fernández-Palanca, Tania Payo-Serafín, et al. · Cancers · 20
PDF
Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications
2023 · Paula Fernández-Palanca, Tania Payo-Serafín, et al. · Clinical and Molecular Hepatology · 17
PDF
Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib
2021 · Flavia Fondevila, Carolina Méndez-Blanco, et al. · International Journal of Molecular Sciences · 16
PDF
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
2024 · Tania Payo‐Serafín, Carolina Méndez‐Blanco, et al. · Clinical Pharmacology & Therapeutics · 9
PDF
Inhibition of PERK signaling suppresses tumor progression and blocks GP73-GRP78-dependent stromal activation in hepatocellular carcinoma
2026 · Jaafar Khaled, Maria Kopsida, et al. · Neoplasia · 1
SAT-112 Role of hypoxia on the progression and survival of hepatocellular carcinoma in hypoxia-inducible factor 1 alpha knockout bi- and tri-dimensional in vitro models
2025 · Tania Payo-Serafín, Jennifer Martínez-Geijo, et al. · Journal of Hepatology · 1
Correction: Fondevila et al. Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis. Cancers 2021, 13, 5349
2025 · Flavia Fondevila, Paula Fernández-Palanca, et al. · Cancers · 1
PDF
Irinotecan induces intestinal atrophy and compromises duodenal motility and mucosal permeability: in vivo and in vitro evaluations
2026 · Nathalie Arendt, Tania Payo-Serafín, et al. · Cancer Chemotherapy and Pharmacology
PDF
Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients
2026 · Nathalie Arendt, Tania Payo-Serafín, et al. · Therapeutic Advances in Medical Oncology
Impeding hypoxia-driven tumor progression in hepatocellular carcinoma: clinical and pre-clinical analyses using 2D and 3D in vitro models
2026 · Tania Payo-Serafín, Carolina Méndez-Blanco, et al. · Biology Direct
25 - Hipoxia En El Carcinoma Hepatocelular Humano: Identificación De Genes De Expresión Diferencial Mediante Análisis Bioinformático
2026 · Jennifer Martínez-Geijo, Tania Payo-Serafín, et al. · Gastroenterología y Hepatología
5 - Bloqueo Del Factor Inducible Por Hipoxia 1? Como Adyuvante a La Terapia Con Inhibidores Tirosina Quinasa En El Hepatocarcinoma
2026 · Tania Payo-Serafín, Jennifer Martínez-Geijo, et al. · Gastroenterología y Hepatología
200P Targeting hypoxia-inducible factor 1α to suppress hypoxia-mediated progression and invasion of hepatocellular carcinoma
2025 · T. Payo-Serafín, J. Martínez-Geijo, et al. · Annals of Oncology
PDF
201P Exploring differentially expressed genes associated with HIF1A and tumor proliferation in hepatocellular carcinoma: Bioinformatics and in vivo study
2025 · J. Martínez-Geijo, T. Payo-Serafín, et al. · Annals of Oncology
PDF
WED-115 Differential gene expression in hepatocellular carcinoma: a bioinformatic approach to correlate with HIF1A
2025 · Jennifer Martínez-Geijo, Tania Payo-Serafín, et al. · Journal of Hepatology
180P A systematic review with meta-analysis of risks and benefits of tyrosine kinase inhibitors in hepatocellular carcinoma treatment
2024 · J. Martínez-Geijo, T. Payo-Serafín, et al. · Annals of Oncology
PDF
966P Potential role of neuropilin-1 in the prognosis, development and risk of invasion in hepatocellular carcinoma patients
2023 · T. Payo-Serafín, P. Fernández Palanca, et al. · Annals of Oncology
PDF
Relevance of hypoxia-inducible factor 1 alpha in hepatocellular carcinoma: clinical and pre-clinical analysis
2023 · Tania Payo-Serafín, Paula Fernández-Palanca, et al. · Journal of Hepatology
Role of autophagy-mediated neuropilin-1 degradation on lenvatinib efficacy in human hepatocarcinoma
2022 · Paula Fernández-Palanca, Tania Payo-Serafín, et al. · Journal of Hepatology
Works count: 21
Citation count: 128
H-index: 6
I10-index: 5
Year
Topic
Type